Regeneron Pharmaceuticals (NASDAQ:REGN) shares experienced a significant 19% drop on Friday, May 30, following the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD ...

Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...

U.S. stock markets were muted and closed mixed on Monday. Market participants’ sentiments were subdued following the reinitiation of trade talks between the United States and China. The Nasdaq ...

The S&P 500 edged 0.1% higher on Monday, June 9, as the initiation of talks between the U.S. and China raised optimism around ...

Sanofi (NASDAQ:SNY)’s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with ...

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...

Job openings in the U.S. rose in April even after President Donald Trump jacked up tariffs on the rest of the world, but companies were slow to fill new positions amid the worst trade wars since the ...

Regeneron Pharmaceuticals, Inc. (REGN) key stats comparison: compare with other stocks by metrics ... Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities ...